
StoneX Group (SNEX) is rated Buy with an 18% upside to a $67 fair value, driven by strong profitability and successful cost synergies following its acquisition of R.J. O'Brien. The company's flexible cost structure supports earnings even in slow periods, and client float income remains stable without needing high market volatility. Fiscal Q4 results are expected to surpass consensus estimates, benefiting from record volumes at CME and ongoing cost savings. Risks include potential volatility normalization, interest rate drops, and execution challenges on acquisitions, but the current valuation near 13.6 times FY27 EPS presents an attractive entry point for investors.
StoneX Group (SNEX) is trading at USD 56.82 on Pluang as of Oct 22, 2026 21:41 WIB, down 1.06% for the day. This price is notably below its 52-week high of USD 92.67 but well above the 52-week low of USD 37.20, indicating a mid-range position within its yearly trading band. The current market cap stands at $6.93 billion, reflecting investor valuation amid the company's earnings outlook and cost synergy achievements.